Mark Wood

Person

Burnaby, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Targeted compositions
- Patent number 12,043,833
- Issue date Jul 23, 2024
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted nucleic acid conjugate compositions
- Patent number 11,896,672
- Issue date Feb 13, 2024
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted compositions
- Patent number 11,427,823
- Issue date Aug 30, 2022
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Trialkyl cationic lipids and methods of use thereof
- Patent number 11,395,854
- Issue date Jul 26, 2022
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyridinone-containing trycyclic compounds, and methods...
- Patent number 11,013,726
- Issue date May 25, 2021
- ARBUTUS BIOPHARMA CORPORATION
- Laurèn Danielle Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyridinone-containing trycyclic compounds, and methods...
- Patent number 10,821,103
- Issue date Nov 3, 2020
- ARBUTUS BIOPHARMA CORPORATION
- Laurèn Danielle Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trialkyl cationic lipids and methods of use thereof
- Patent number 10,561,732
- Issue date Feb 18, 2020
- Arbutus Biopharma Corporation
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic cationic lipids and methods of use
- Patent number 10,077,232
- Issue date Sep 18, 2018
- Arbutus Biopharma Corporation
- James Heyes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-oxindole compounds and their use as therapeutic agents
- Patent number 9,458,178
- Issue date Oct 4, 2016
- Xenon Pharmaceuticals Inc.
- Mikhail Chafeev
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trialkyl cationic lipids and methods of use thereof
- Patent number 9,352,042
- Issue date May 31, 2016
- Protiva Biotherapeutics, Inc.
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cationic lipids and methods of use thereof
- Patent number 9,126,966
- Issue date Sep 8, 2015
- Protiva Biotherapeutics, Inc.
- Alan Martin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Spiro-oxindole compounds and their use as therapeutic agents
- Patent number 8,916,580
- Issue date Dec 23, 2014
- Xenon Pharmaceuticals Inc.
- Mikhail Chafeev
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for silencing apolipoprotein B
- Patent number 8,865,675
- Issue date Oct 21, 2014
- Protiva Biotherapeutics, Inc.
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trialkyl cationic lipids and methods of use thereof
- Patent number 8,466,122
- Issue date Jun 18, 2013
- Protiva Biotherapeutics, Inc.
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-oxindole compounds and their uses as therapeutic agents
- Patent number 8,415,370
- Issue date Apr 9, 2013
- Xenon Pharmaceuticals Inc.
- Mikhail Chafeev
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-oxindole compounds and their use as therapeutic agents
- Patent number 8,263,606
- Issue date Sep 11, 2012
- Xenon Pharmaceuticals Inc.
- Mikhail Chafeev
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-oxindole compounds and their use as therapeutic agents
- Patent number 8,101,647
- Issue date Jan 24, 2012
- Xenon Pharmaceuticals Inc.
- Mikhail Chafeev
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS
- Publication number 20240245784
- Publication date Jul 25, 2024
- ARBUTUS BIOPHARMA CORPORATION
- James HEYES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PEG LIPIDS AND LIPID NANOPARTICLES
- Publication number 20240148663
- Publication date May 9, 2024
- GENEVANT SCIENCES GMBH
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
- Publication number 20230165973
- Publication date Jun 1, 2023
- ARBUTUS BIOPHARMA CORPORATION
- James HEYES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED COMPOSITIONS
- Publication number 20230110295
- Publication date Apr 13, 2023
- ARBUTUS BIOPHARMA CORPORATION
- James HEYES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20230109183
- Publication date Apr 6, 2023
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATES AND METHODS FOR TREATING LIVER FIBROSIS
- Publication number 20220387600
- Publication date Dec 8, 2022
- GENEVANT SCIENCES GMBH
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATES AND METHODS FOR TREATING ACROMEGALY
- Publication number 20220288214
- Publication date Sep 15, 2022
- GENEVANT SCIENCES GMBH
- Drew KONDRATOWICZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CATIONIC LIPIDS CONTAINING SILICON
- Publication number 20220133636
- Publication date May 5, 2022
- Michael J. ABRAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEGATIVELY CHARGED PEG-LIPID CONJUGATES
- Publication number 20220072154
- Publication date Mar 10, 2022
- Arbutus Biopharma Corporation
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIVALENT TARGETED CONJUGATES
- Publication number 20220062323
- Publication date Mar 3, 2022
- Arbutus Biopharma Corporation
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED COMPOSITIONS
- Publication number 20200407724
- Publication date Dec 31, 2020
- Arbutus Biopharma Corporation
- James HEYES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20200306378
- Publication date Oct 1, 2020
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
- Publication number 20200297870
- Publication date Sep 24, 2020
- Arbutus Biopharma Corporation
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20200282060
- Publication date Sep 10, 2020
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBSTITUTED PYRIDINONE-CONTAINING TRYCYCLIC COMPOUNDS, AND METHODS...
- Publication number 20200261432
- Publication date Aug 20, 2020
- ARBUTUS BIOPHARMA CORPORATION
- Laurèn Danielle Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDINONE-CONTAINING TRYCYCLIC COMPOUNDS, AND METHODS...
- Publication number 20190314347
- Publication date Oct 17, 2019
- ARBUTUS BIOPHARMA CORPORATION
- Danielle Lauren BAILEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS
- Publication number 20190160176
- Publication date May 30, 2019
- Arbutus Biopharma Corporation
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE
- Publication number 20190106379
- Publication date Apr 11, 2019
- ARBUTUS BIOPHARMA CORPORATION
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20170151333
- Publication date Jun 1, 2017
- Protiva Biotherapeutics, Inc.
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
- Publication number 20170114075
- Publication date Apr 27, 2017
- Xenon Pharmaceuticals Inc.
- Mikhail Chafeev
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20170007702
- Publication date Jan 12, 2017
- Protiva Biotherapeutics, Inc.
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
- Publication number 20160256568
- Publication date Sep 8, 2016
- Protiva Biotherapeutics, Inc.
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
- Publication number 20160256567
- Publication date Sep 8, 2016
- Protiva Biotherapeutics, Inc.
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
- Publication number 20160151284
- Publication date Jun 2, 2016
- Protiva Biotherapeutics, Inc.
- James HEYES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
- Publication number 20150291623
- Publication date Oct 15, 2015
- Xenon Pharmaceuticals Inc.
- Mikhail Chafeev
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20150064242
- Publication date Mar 5, 2015
- Protiva Biotherapeutics, Inc.
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20140288146
- Publication date Sep 25, 2014
- Protiva Biotherapeutics, Inc.
- James Heyes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
- Publication number 20130252962
- Publication date Sep 26, 2013
- Mikhail CHAFEEV
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF
- Publication number 20130123338
- Publication date May 16, 2013
- Protiva Biotherapeutics, Inc.
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR SILENCING APOLIPOPROTEIN B
- Publication number 20130123339
- Publication date May 16, 2013
- PROTIVA BIOTHERAPEUTICS INC
- James Heyes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Person

Patents Grantslast 30 patents

Targeted compositions

Targeted nucleic acid conjugate compositions

Targeted compositions

Trialkyl cationic lipids and methods of use thereof

Substituted pyridinone-containing trycyclic compounds, and methods...

Substituted pyridinone-containing trycyclic compounds, and methods...

Trialkyl cationic lipids and methods of use thereof

Cyclic cationic lipids and methods of use

Spiro-oxindole compounds and their use as therapeutic agents

Trialkyl cationic lipids and methods of use thereof

Cationic lipids and methods of use thereof

Spiro-oxindole compounds and their use as therapeutic agents

Compositions and methods for silencing apolipoprotein B

Trialkyl cationic lipids and methods of use thereof

Spiro-oxindole compounds and their uses as therapeutic agents

Spiro-oxindole compounds and their use as therapeutic agents

Spiro-oxindole compounds and their use as therapeutic agents

Patents Applicationslast 30 patents

TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS

PEG LIPIDS AND LIPID NANOPARTICLES

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

TARGETED COMPOSITIONS

TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF

CONJUGATES AND METHODS FOR TREATING LIVER FIBROSIS

CONJUGATES AND METHODS FOR TREATING ACROMEGALY

CATIONIC LIPIDS CONTAINING SILICON

NEGATIVELY CHARGED PEG-LIPID CONJUGATES

BIVALENT TARGETED CONJUGATES

TARGETED COMPOSITIONS

TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF

SUBSTITUTED PYRIDINONE-CONTAINING TRYCYCLIC COMPOUNDS, AND METHODS...

SUBSTITUTED PYRIDINONE-CONTAINING TRYCYCLIC COMPOUNDS, AND METHODS...

TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS

NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE

NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF

SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF

NOVEL TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF

SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR SILENCING APOLIPOPROTEIN B